Bayesian Designs For Phase I–ii Clinical Trials

Bayesian Designs for Phase I–II Clinical Trials  eBooks & eLearning

Posted by interes at Dec. 10, 2016
Bayesian Designs for Phase I–II Clinical Trials

Bayesian Designs for Phase I–II Clinical Trials by Ying Yuan and Hoang Q. Nguyen
English | 2016 | ISBN: 1498709559 | 324 pages | PDF | 25,6 MB

Phase I Cancer Clinical Trials: A Practical Guide (2nd edition) (Repost)  eBooks & eLearning

Posted by bookwarrior at Aug. 7, 2016
Phase I Cancer Clinical Trials: A Practical Guide (2nd edition) (Repost)

Phase I Cancer Clinical Trials: A Practical Guide (2nd edition) By Elizabeth A. Eisenhauer, Christopher Twelves, Marc Buyse
2014 | 368 Pages | ISBN: 0199359016 | PDF | 11 MB

Phase I Cancer Clinical Trials: A Practical Guide (2nd edition) (Repost)  eBooks & eLearning

Posted by tukotikko at March 7, 2016
Phase I Cancer Clinical Trials: A Practical Guide (2nd edition) (Repost)

Phase I Cancer Clinical Trials: A Practical Guide (2nd edition) By Elizabeth A. Eisenhauer, Christopher Twelves, Marc Buyse
2014 | 368 Pages | ISBN: 0199359016 | PDF | 11 MB

Phase I Cancer Clinical Trials: A Practical Guide  eBooks & eLearning

Posted by nebulae at Feb. 25, 2015
Phase I Cancer Clinical Trials: A Practical Guide

Elizabeth A. Eisenhauer and Christopher Twelves, "Phase I Cancer Clinical Trials: A Practical Guide"
English | ISBN: 0199359016 | 2015 | 368 pages | PDF | 3 MB

Clinical Trial Design: Bayesian and Frequentist Adaptive Methods (Repost)  eBooks & eLearning

Posted by nebulae at Oct. 22, 2015
Clinical Trial Design: Bayesian and Frequentist Adaptive Methods (Repost)

Guosheng Yin, "Clinical Trial Design: Bayesian and Frequentist Adaptive Methods"
English | 2012 | ISBN: 0470581719 | 364 pages | PDF | 6,5 MB

Bayesian Adaptive Methods for Clinical Trials (repost)  eBooks & eLearning

Posted by interes at Jan. 29, 2014
Bayesian Adaptive Methods for Clinical Trials (repost)

Bayesian Adaptive Methods for Clinical Trials by Scott M. Berry, Bradley P. Carlin, J. Jack Lee, Peter Muller
English | ISBN: 1439825483 | 2010 | PDF | 311 pages | 2,9 mb

Already popular in the analysis of medical device trials, adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseases and conditions, from Alzheimer’s disease and multiple sclerosis to obesity, diabetes, hepatitis C, and HIV.

Clinical Trial Design: Bayesian and Frequentist Adaptive Methods  eBooks & eLearning

Posted by interes at Aug. 2, 2013
Clinical Trial Design: Bayesian and Frequentist Adaptive Methods

Clinical Trial Design: Bayesian and Frequentist Adaptive Methods by Guosheng Yin
English | 2012 | ISBN: 0470581719 | 364 pages | PDF | 6,5 MB

A balanced treatment of the theories, methodologies, and design issues involved in clinical trials using statistical methods
There has been enormous interest and development in Bayesian adaptive designs, especially for early phases of clinical trials.

Bayesian Adaptive Methods for Clinical Trials (repost)  eBooks & eLearning

Posted by arundhati at July 9, 2013
Bayesian Adaptive Methods for Clinical Trials (repost)

Scott M. Berry, Bradley P. Carlin, J. Jack Lee, "Bayesian Adaptive Methods for Clinical Trials"
2010 | ISBN: 1439825483 | PDF | 311 pages | 4 MB

Clinical Trials in Neurology: Design, Conduct, Analysis (repost)  eBooks & eLearning

Posted by arundhati at Dec. 16, 2016
Clinical Trials in Neurology: Design, Conduct, Analysis (repost)

Bernard Ravina, Jeffrey Cummings, "Clinical Trials in Neurology: Design, Conduct, Analysis"
2012 | ISBN: 0521762596 | English | 386 pages | PDF | 6 MB

Clinical Trials in the Neurosciences  eBooks & eLearning

Posted by leonardo78 at Feb. 13, 2016
Clinical Trials in the Neurosciences

Clinical Trials in the Neurosciences by K.M. Woodbury-Harris, B.M. Coull, J. Bogousslavsky
Publisher: S. Karger | 2009 | ISBN: 3805590237 | 214 pages | PDF | 3,1 MB

A properly designed and executed clinical trial that addresses an import question and delivers a definitive result can change the practice of medicine worldwide. This book encompasses a bench-to-bedside approach and serves as an excellent guidance for translating preclinical studies to early phase I/II and phase III trials. In the first part, the book covers preclinical science with respect to animal models of various neurological diseases, FDA requirements for preclinical studies, translation of animal to patient studies and scaling up from animal to human studies.